Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii

被引:203
作者
Poirel, L [1 ]
Nordmann, P [1 ]
机构
[1] Univ Paris 11, Serv Bacteriol Virol, Hop Paris, Fac Med Paris Sud,Hop Bicetre, F-94275 Le Kremlin Bicetre, France
关键词
D O I
10.1128/AAC.50.4.1442-1448.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Genetic structures surrounding the carbapenem-hydrolyzing oxacillinase gene bla(OXA-58) were characterized in a series of OXA-58-positive Acinetobacter baumannii strains isolated from different countries. We showed that in most of the cases, acquisitions of the bla(OXA)-58-containing overall structure, including insertion sequence elements, may be likely the results of recombination events. In type strain A. baumannii MAD, the genetic structure surrounding the bla(OXA-58) gene was bracketed by two 27-bp repeated sequences. The isolation of a clonally related OXA-58-negative A. baumannii isolate that possessed the same plasmid backbone as A. baumannii MAD but lacked this genetic structure indicated that the mechanism of acquisition could be reversible. Parts of the structure identified in A. baumannii MAD were conserved in other bla(OXA-58)-positive isolates from various European countries. Primer extension experiments showed that blaOXA-58 expression was related to promoter sequences brought by different insertion sequence elements, such as an ISAba3-like element, ISAba1, ISAba2, and IS18. This work identified novel structures at the origin of acquisition and expression of a carbapenem-hydrolyzing P-lactamase identified in non-clonally related A. baumannii isolates.
引用
收藏
页码:1442 / 1448
页数:7
相关论文
共 29 条
[1]   Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii [J].
Afzal-Shah, M ;
Woodford, N ;
Livermore, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :583-588
[2]   Novel genetic structure associated with an extended-spectrum β-lactamase blaVEBGene in a Providencia stuartii clinical isolate from Algeria [J].
Aubert, D ;
Naas, T ;
Lartigue, MF ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3590-3592
[3]   Functional and structural characterization of the genetic environment of an extended-spectrum β-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India [J].
Aubert, D ;
Girlich, D ;
Naas, T ;
Nagarajan, S ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3284-3290
[4]   OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain [J].
Bou, G ;
Oliver, A ;
Martínez-Beltran, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1556-1561
[5]   The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents [J].
Brown, S ;
Amyes, SGB .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (04) :326-329
[6]   Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina [J].
Brown, S ;
Young, HK ;
Amyes, SGB .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (01) :15-23
[7]   AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains [J].
Corvec, S ;
Caroff, N ;
Espaze, E ;
Giraudeau, C ;
Drugeon, H ;
Reynaud, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (04) :629-635
[8]   Integration of foreign DNA during natural transformation of Acinetobacter sp by homology-facilitated illegitimate recombination [J].
de Vries, J ;
Wackernagel, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) :2094-2099
[9]   Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii [J].
Héritier, C ;
Poirel, L ;
Nordmann, P .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (02) :123-130
[10]   Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii [J].
Héritier, C ;
Poirel, L ;
Lambert, T ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3198-3202